The Supreme Court’s decision to overturn Chevron deference in Loper Bright v. Raimondo, which requires courts to independently interpret ambiguous and silent statutes rather than deferring to federal agencies, is likely to significantly impact the health care industry. In a new insight, Health Care Policy Analyst John Walker and Henry Roberts examine three cases where the decision could be pivotal.

Walker and Roberts conclude:

The Supreme Court’s decision to overturn Chevron deference in Loper Bright v. Raimondo marks a major shift in regulatory oversight within the health care sector. By requiring courts to independently interpret ambiguous statutes, this ruling affects key areas such as drug and device definitions and reimbursement determinations. As a result, Congress now faces the imperative to provide clear legislative guidance and potentially even expand agency authority in technically complex domains to foster effective health care regulation. The outcomes of ongoing legal battles will further shape the future landscape of health care policy and regulation after Chevron.

Read the analysis